10x Genomics Sets August 6 Date for Q2 2026 Earnings
Pleasanton-based life science firm 10x Genomics will disclose its financial performance for the second quarter of 2026 on August 6, following the close of regular market trading. The company plans to host a live conference call and webcast to unpack its latest business developments and forward-looking projections for investors.
The earnings announcement is scheduled for release shortly before the conference call, which begins at 1:30 p.m. Pacific Time. Interested participants can access the live audio feed through the investor relations portal on the company’s official website. A replay of the discussion will remain available for public viewing for at least 45 days following the event.
10x Genomics specializes in integrated research solutions, including instruments and software designed for single-cell and spatial biology. These technologies currently support research initiatives across oncology, immunology, and neuroscience. The company maintains compliance with regulatory disclosure requirements by utilizing its website and SEC filings to distribute material information to the market.
Comments (0)
No comments yet. Be the first!